These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15304052)

  • 21. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
    Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L
    PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.
    Jin J; Tomlinson W; Kirk IP; Kim YB; Humphries RG; Kunapuli SP
    Br J Pharmacol; 2001 Jun; 133(4):521-8. PubMed ID: 11399669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.
    Kobsar AL; Koessler J; Rajkovic MS; Brunner KP; Steigerwald U; Walter U
    Platelets; 2010; 21(2):112-6. PubMed ID: 20085435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
    Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    J Thromb Haemost; 2010 Jan; 8(1):37-42. PubMed ID: 19818001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases.
    Aleil B; Ravanat C; Cazenave JP; Rochoux G; Heitz A; Gachet C
    J Thromb Haemost; 2005 Jan; 3(1):85-92. PubMed ID: 15634270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The P2 receptors in platelet function.
    Hechler B; Cattaneo M; Gachet C
    Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The P2 receptors and congenital platelet function defects.
    Cattaneo M
    Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
    J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1.
    Fox SC; Behan MW; Heptinstall S
    Cell Calcium; 2004 Jan; 35(1):39-46. PubMed ID: 14670370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose.
    von Beckerath N; von Beckerath O; Koch W; Eichinger M; Schömig A; Kastrati A
    Blood Coagul Fibrinolysis; 2005 Apr; 16(3):199-204. PubMed ID: 15795539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of clopidogrel resistance.
    Almsherqi ZA; McLachlan C; Mossop PJ; Deng Y
    Thromb Res; 2005; 116(5):451-3. PubMed ID: 16039696
    [No Abstract]   [Full Text] [Related]  

  • 33. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.
    Cattaneo M
    Blood; 2011 Feb; 117(7):2102-12. PubMed ID: 20966167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel.
    Judge HM; Patil SB; Buckland RJ; Jakubowski JA; Storey RF
    J Thromb Haemost; 2010 Aug; 8(8):1820-7. PubMed ID: 20492465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
    Lood C; Amisten S; Gullstrand B; Jönsen A; Allhorn M; Truedsson L; Sturfelt G; Erlinge D; Bengtsson AA
    Blood; 2010 Sep; 116(11):1951-7. PubMed ID: 20538795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
    Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
    Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
    Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
    J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
    Packham MA; Mustard JF
    Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.